Clinical trial

Latanoprost Versus Tafluprost: 24-hour Intraocular Pressure (IOP)

NCT01162603

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DEVICE · Unmapped registry intervention Goldmann and Perkins applanation tonometry Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention TAFLUPROST 0.0015% EYEDROPS Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention LATANOPROST 0.005% EYEDROPS Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Latanoprost Versus Tafluprost: 24-hour Intraocular Pressure (IOP)

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-03-01

PhasePHASE4

Conditions

Primary Open Angle Glaucomaunresolved

Ocular Hypertensionverified · MONDO: ocular hypertension

Interventions

Goldmann and Perkins applanation tonometryDEVICE

TAFLUPROST 0.0015% EYEDROPSDRUG

LATANOPROST 0.005% EYEDROPSDRUG

Sponsors & collaborators

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescialead sponsor

Aristotle University Of Thessalonikicollaborator

Mapped research locations

ThessalonikiGreece1 BresciaItaly1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01162603 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.